340B Health

340B Insight Podcast

340B Insight

340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.

Listen and Subscribe

Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org

Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org

Follow 340B Health on Twitter, Facebook, and LinkedIn

 


Episodes

  • Episode 67: Maureen Testoni‚Äôs Outlook for 340B in 2023

    Several 340B developments have occurred in the first weeks of 2023, with many more expected to come this year. In this episode, we speak with 340B Health President and CEO Maureen Testoni about her outlook for 340B. Our discussion includes her analysis of the latest in the 340B contract pharmacy dispute, the 340B advocacy landscape at the federal and state levels, and Medicare issues affecting 340B.

    *Editor’s note: We spoke with Maureen prior to Bayer and EMD Serono announcing they will restrict 340B discounts. When these restrictions start in March, at least 21 companies will be limiting 340B discounts, with 14 of these companies conditioning 340B pricing on providers sharing contract pharmacy claims data.* (Transcript)

    Read more

  • Episode 66: Your 340B Questions Answered

    We often receive listener questions about 340B issues and developments that affect professionals in the 340B world. In this episode, we open the listener virtual mailbag and answer some of your questions with help from our 340B Health staff experts. Some of the questions we tackle include queries about mitigating 340B contract pharmacy restrictions, understanding 340B patient definition, analyzing current 340B hospital audit trends, and examining Medicare Advantage payment rates for 340B drugs. (Transcript)

    Read more

  • Episode 65: Home Infusion and 340B Considerations

    Providing care beyond hospital walls is a growing trend for 340B hospitals. One service that health systems provide outside of the hospital setting is home infusion care. On our first episode of 2023, we are joined by David Klinger and Seth Gazes from Geisinger Health to hear how 340B hospitals can establish home infusion care and the 340B considerations they should keep in mind. Prior to the interview, we provide an update on the 19th drug company to restrict 340B discounts for drugs dispensed at community and specialty contract pharmacies. We also recap drug manufacturer 340B overcharge notices in 2022. (Transcript)

    Read more

  • Episode 64: Educating Your Hospital Colleagues About 340B

    340B professionals are not the only hospital staff who need to know about 340B. That is why it is important that 340B professionals educate their colleagues about the program and what it means for clinical care and patient care operations. For our final episode of the year, 340B professional Ryan Atherton joins us to share the strategies he has deployed to help his colleagues better understand 340B’s role in the patient care mission. Ryan formerly was the 340B program manager at Yakima Valley Memorial Hospital in Washington State. He improved understanding of 340B among the hospital’s staff, which led to a more efficient program. Before the interview, we share a news update on HRSA’s new proposed rule for 340B administrative dispute resolution (ADR). (Transcript)

    Read more

  • Episode 63: What the Midterm Election Results Mean for 340B

    The recent election results have implications for the future of U.S. health policy and the 340B program. Health policy experts Debbie Curtis and Rodney Whitlock join us this week to discuss how the new Congress will affect 340B and how individuals can best engage in educating and advocating for the program. Debbie and Rodney are vice presidents at McDermott + Consulting and previously were congressional staffers. Before the interview, we provide an update on the litigation process in the 340B contract pharmacy dispute, and we recap HRSA audit results of drug companies. (Transcript)

    Read more

  • Episode 62: Managing 340B in a Rural Hospital

    Nov. 17 is National Rural Health Day, which is an opportunity to celebrate the importance of rural hospitals to patients living in remote communities. We are joined by Karen McCombs, 340B program manager for Wills Memorial Hospital in Georgia. Karen shares her tips for managing her critical access hospital’s 340B program in a compliant and efficient manner to support patient care initiatives. Before the interview, we provide updates on the 2023 Medicare payment rate for 340B drugs and on the status of 340B contract pharmacy litigation pending in federal appeals courts. (Transcript)

    Read more